Arrivent Biopharma Inc (AVBP)

R&D Expenses

$42.34M

Quarterly · Period ending: · USD

AVBP logo

AVBP R&D Expenses

Latest reported$42.34M
AVBP Quarterly R&D Expenses ($5.85M → $42.34M)
High-resolution chart · PNG

AVBP r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arrivent Biopharma Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
42,339,000
37,617,000
32,175,000
32,167,000
27,720,000
61,289,000
20,163,000
20,088,000
21,778,000
16,975,000
20,010,000
14,280,000
20,358,000
10,236,000
8,647,000
10,089,000
5,848,500
5,848,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.